A Bull Market Continues To Unfold On Oramed Pharmaceuticals, Inc (NASDAQ: ORMP), As It Continued To Rise 6.20% In Year-To-Date
During the last session, Oramed Pharmaceuticals, Inc (NASDAQ:ORMP)’s traded shares were 0.36 million, with the beta value of the company hitting 1.48. At the end